Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06842771 · ClinicalTrials.gov registry record · Phase 4
Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery
A Phase 4 study, sponsored by University of Tennessee.
- Not yet
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
NCT06842771: Clinical Trial Phase 4 study, sponsored by University of Tennessee.
NCT06842771 is a Phase 4 study that has not yet begun recruiting, run by University of Tennessee. The registered enrollment target is 96 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06842771, a Phase 4 study, has not yet begun recruiting, sponsored by University of Tennessee.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
Study Summary
We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid use postoperatively.
Primary Outcome
At approximately 24 hours after surgery completion, we will contact the participant in person if still hospitalized, or via telephone if discharged home, to ask what their pain level is (utilizing the VAS) and how many opioid tablets (mg dosage and number) they have used since hospital discharge.
Interventions
- OTHER Normal Saline (0.9% NaCl)
- DRUG Marcaine hydrochloride without epinephrine 0.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2025-03 |
| Est. Completion | 2027-03 |
| Phase | Phase 4 |
What is known before NCT06842771 opens enrollment
NCT06842771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal Saline (0.9% NaCl) is the first listed.
NCT06842771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06842771 about?
NCT06842771 is a clinical study titled "Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery". We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid us...
What is the current status of trial NCT06842771?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2025-03. Estimated completion is 2027-03.
What interventions are being tested in trial NCT06842771?
The interventions under investigation include: Normal Saline (0.9% NaCl) (OTHER), Marcaine hydrochloride without epinephrine 0.5% (DRUG).
Who is sponsoring clinical trial NCT06842771?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06842771's enrollment target sits among peer trials
96 863rd of 2000 higher than 1,132 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia